NJ Appeals Court Will Hear Nostrum Attys' Fee Fight

Law360, New York (December 6, 2013, 10:12 PM EST) -- A New Jersey appeals court will hear a case brought by a law firm that sued Nostrum Laboratories Inc. for refusing to pay for its representation of a putative patent holder to a generic drug formulation in underlying litigation over a noncompete agreement, according to a Friday order.

The Superior Court of New Jersey, Appellate Division will hear the case after the Supreme Court of New Jersey granted Pashman Stein PC’s motion to appeal a July trial court decision ordering Nostrum to partially pay the firm’s...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.